Explore CACNA1G gene products and cross-species
research data at TarMart platform. Discover comprehensive
biological information, expression tools, and therapeutic
insights for Homo sapiens (human), Cynomolgus monkeys, rodents
(mouse/rat), canines, felines, bovines, and equines. Your
premier destination for multi-species gene research solutions
Target
sublocation: Transmembrane Protein.
Voltage-sensitive calcium channels mediate the entry of calcium ions into excitable cells, and are also involved in a variety of calcium-dependent processes, including muscle contraction, hormone or neurotransmitter release, gene expression, cell motility, cell division, and cell death. This gene encodes a T-type, low-voltage activated calcium channel. The T-type channels generate currents that are both transient, owing to fast inactivation, and tiny, owing to small conductance. T-type channels are thought to be involved in pacemaker activity, low-threshold calcium spikes, neuronal oscillations and resonance, and rebound burst firing. Many alternatively spliced transcript variants encoding different isoforms have been described for this gene. [provided by RefSeq, Sep 2011]
| Target ID |
GM-T64795
|
| Target Name |
CACNA1G
|
Gene Group ldentifer
（Target Gene ID in Homo
species)
|
8913
|
| Gene ID |
100070000 (Equus caballus), 101098757 (Felis catus), 12291 (Mus musculus), 282411 (Bos taurus)
29717 (Rattus norvegicus), 491083 (Canis lupus familiaris), 706230 (Macaca mulatta), 8913 (Homo sapiens)
|
| Target Alternative Names |
CACNA1G,Ca(V)T.1,Ca(v)3.1,Cacna1g,Cav3.1,Cav3.1c,Cav3.1d,NBR13,SCA42,SCA42ND,Voltage-dependent T-type calcium channel subunit alpha-1G,Voltage-gated calcium channel subunit alpha Cav3.1,[a]1G,a1G,alpha-1G,mKIAA1123
|
| Uniprot Accession |
O54898,O43497
|
| Protein Sub-location |
Transmembrane Protein
|
| Category |
Therapeutics Target
|
| Disease |
cancer
|
| Disease from KEGG |
MAPK signaling pathway, Calcium signaling pathway, Circadian entrainment, Aldosterone synthesis and secretion, Cortisol synthesis and secretion, GnRH secretion, Type II diabetes mellitus, Cushing syndrome
|
| Gene Ensembl |
ENSECAG00000015461, ENSMUSG00000020866, ENSBTAG00000009835, ENSCAFG00845013736, ENSMMUG00000017256, ENSG00000006283
|
| Target Classification |
Tumor-associated antigen (TAA)
|
CACNA1G siRNA/miRNA/oligo for RNA interfence (RNAi)
| Cat No. | Product Name | GeneID | Species | Grade | Detail |
|---|
| pGMoligo8913 | Pre-made Human CACNA1G/NBR13/SCA42 siRNA oligo Duplex | 8913 | Human | In-vitro grade; in-vivo grade | Detail |
| pGMoligo29717 | Pre-made Rat Cacna1g siRNA oligo Duplex | 29717 | Rat | In-vitro grade; in-vivo grade | Detail |
| pGMoligo12291 | Pre-made Mouse Cacna1g/a1G/[a]1G siRNA oligo Duplex | 12291 | Mouse | In-vitro grade; in-vivo grade | Detail |
| pGMoligo706230 | Pre-made Cynomolgus/Rhesus macaque CACNA1G siRNA oligo Duplex | 706230 | Cynomolgus/Rhesus macaque | In-vitro grade; in-vivo grade | Detail |
| pGMoligo101098757 | Pre-made Cat/Feline CACNA1G siRNA oligo Duplex | 101098757 | Cat/Feline | In-vitro grade; in-vivo grade | Detail |
| pGMoligo491083 | Pre-made Dog/Canine CACNA1G/Ca(v)3.1 siRNA oligo Duplex | 491083 | Dog/Canine | In-vitro grade; in-vivo grade | Detail |
| pGMoligo282411 | Pre-made Bovines/Cattle CACNA1G siRNA oligo Duplex | 282411 | Bovines/Cattle | In-vitro grade; in-vivo grade | Detail |
| pGMoligo100070000 | Pre-made Equine/Horse CACNA1G siRNA oligo Duplex | 100070000 | Equine/Horse | In-vitro grade; in-vivo grade | Detail |
CACNA1G antibody/GMab
| Cat No. | Species | Antibody Name | Format | Classified by tag | Detail |
|---|
| GM-Tg-hg-T64795-Ab | Human | Anti-Human CACNA1G monoclonal antibody | mab | FACS/Biofunctional Antibody, Therapeutics Target antibody | Detail |
| GM-Tg-rg-T64795-Ab | Rat | Anti-Rat CACNA1G monoclonal antibody | mab | FACS/Biofunctional Antibody, Therapeutics Target antibody | Detail |
| GM-Tg-mg-T64795-Ab | Mouse | Anti-Mouse CACNA1G monoclonal antibody | mab | FACS/Biofunctional Antibody, Therapeutics Target antibody | Detail |
| GM-Tg-cynog-T64795-Ab | Cynomolgus/Rhesus macaque | Anti-Cynomolgus/Rhesus macaque CACNA1G monoclonal antibody | mab | FACS/Biofunctional Antibody, Therapeutics Target antibody | Detail |
| GM-Tg-felg-T64795-Ab | Cat/Feline | Anti-Cat/Feline CACNA1G monoclonal antibody | mab | FACS/Biofunctional Antibody, Therapeutics Target antibody | Detail |
| GM-Tg-cang-T64795-Ab | Dog/Canine | Anti-Dog/Canine CACNA1G monoclonal antibody | mab | FACS/Biofunctional Antibody, Therapeutics Target antibody | Detail |
| GM-Tg-bovg-T64795-Ab | Bovines/Cattle | Anti-Bovines/Cattle CACNA1G monoclonal antibody | mab | FACS/Biofunctional Antibody, Therapeutics Target antibody | Detail |
| GM-Tg-equg-T64795-Ab | Equine/Horse | Anti-Equine/Horse CACNA1G monoclonal antibody | mab | FACS/Biofunctional Antibody, Therapeutics Target antibody | Detail |
CACNA1G VLP (virus-like particle)/protein
| Cat No. | Species | Antigen Name | Expression Platform | Detail |
|---|
| GM-Tg-hg-T64795-Ag | Human | Human CACNA1G VLP (virus-like particle) | HEK293 | Products Developing |
| GM-Tg-rg-T64795-Ag | Rat | Rat CACNA1G VLP (virus-like particle) | HEK293 | Products Developing |
| GM-Tg-mg-T64795-Ag | Mouse | Mouse CACNA1G VLP (virus-like particle) | HEK293 | Products Developing |
| GM-Tg-cynog-T64795-Ag | Cynomolgus/Rhesus macaque | Cynomolgus/Rhesus macaque CACNA1G VLP (virus-like particle) | HEK293 | Products Developing |
| GM-Tg-felg-T64795-Ag | Cat/Feline | Cat/Feline CACNA1G VLP (virus-like particle) | HEK293 | Products Developing |
| GM-Tg-cang-T64795-Ag | Dog/Canine | Dog/Canine CACNA1G VLP (virus-like particle) | HEK293 | Products Developing |
| GM-Tg-bovg-T64795-Ag | Bovines/Cattle | Bovines/Cattle CACNA1G VLP (virus-like particle) | HEK293 | Products Developing |
| GM-Tg-equg-T64795-Ag | Equine/Horse | Equine/Horse CACNA1G VLP (virus-like particle) | HEK293 | Products Developing |
